Outsourcing

Articles

The companies have entered into a manufacturing agreement for the fill finish supply of lenzilumab for the potential treatment of COVID-19.

Ajinomoto Bio-Pharma Services, Humanigen in Manufacturing Agreement for COVID-19 Biologic

CordenPharma and Moderna extended a strategic manufacturing services agreement for the supply of lipid excipients to be used in Moderna’s vaccine against SARS-CoV-2.

CordenPharma to Manufacture Lipid Excipients for Moderna's Vaccine

Advent manufactured the vaccine doses for the Phase 2/3 clinical trial. 

Advent Delivers Doses of COVID-19 Vaccine Candidate for University of Oxford Clinical Trial

HHS announces $354 million in funding for private industry to manufacture generic drugs in the US from raw materials to finished product.

BARDA Funds US-based Drug Manufacturing Initiative

Vibalogics is contracted to manufacture Janssen's COVID-19 candidate vaccine at its GMP-accredited facility in Cuxhaven, Germany.

Vibalogics Manufactures Clinical Trial Material for Janssen COVID-19 Vaccine Candidate

Hitachi Chemical Advanced Therapeutics Solutions and apceth Biopharma entered into long-term development and manufacturing services agreements for the clinical and commercial supply of multiple bluebird bio therapies.

HCATS, apceth Biopharma Form Strategic Manufacturing Agreements with bluebird bio

CMO Evonik begins capacity expansion of APIs and intermediates at its sites in Dossenheim and Hanau Germany to increase EU supply security for drug products.

Evonik Expands Capacity in Germany

FDA approved hydroxychloroquine sulfate for emergency use as a treatment for some hospitalized patients with COVID-19. 

AMRI Announces Increased Production of Hydroxychloroquine Sulfate for COVID-19 Treatment

Fujifilm allocates production volumes for COVID-19 treatments in 2021 at its Denmark facility.

Fujifilm Diosynth Biotechnologies Reserves Capacity for COVID-19 Therapeutics Accelerator

The goal of the collaboration is to manufacture up to one billion does per year of mRNA-1273, Moderna’s vaccine against the novel coronavirus.

Contract Manufacturing Services